Echocardiographic Evaluation of Cardiac Involvement in Patients with COVID-19

Year 2022, Volume: 15 Issue: 1, 286 - 295, 27.03.2022

Muharrem Said Coşgun

https://doi.org/10.18185/erzifbed.1031154

Abstract

Cardiac involvement in coronavirus disease 2019 (COVID-19) is closely associated with morbidity and mortality. Patients with preexisting cardiovascular disease and/or cardiovascular involvement have poor prognoses. This prospective study aimed to identify patients requiring cardiac function evaluation using echocardiography. Data from 243 patients with a confirmed COVID-19 diagnosis between June and November 2021 were analyzed. The demographic and clinical characteristics of all participants were recorded, and echocardiographic examinations were performed. The patients were divided into two groups according to the presence or absence of abnormalities on echocardiography. Echocardiographic findings were normal in 133 (54.7%) patients and abnormal in 110 (45.3%) patients. Abnormal findings were significantly more common than normal findings in patients requiring intensive care and patients with elevated cardiac biomarker (troponin I and/or brain natriuretic peptide) levels (p < 0.001, in both). Conversely, normal findings were significantly more common than abnormal findings in patients requiring isolated wards and the indication of suspected left and/or right ventricular failure (p < 0.001, in both). The results suggest that high cardiac biomarkers and requiring intensive care may facilitate the selection of patients who can benefit from echocardiographic imaging, which is important given the increased risk of viral transmission when performing echocardiography.

Keywords

COVID-19, cardiac involvement, echocardiograpy, heart failure

References

• Cui S, Chen S, Li X, Liu S and Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of thrombosis and haemostasis : JTH. 2020;18:1421-1424.
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J and Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497-506.
• Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G and Gubbay JB. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. The New England journal of medicine. 2018;378:345-353
• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W and Voigt J-U. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015;28:1-39.e14.
• Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z and Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical research in cardiology : official journal of the German Cardiac Society. 2020;109:531-538.
• Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE and Casscells SW, 3rd. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. European heart journal. 2007;28:1205-10.
• Sharma A, Tiwari S, Deb MK and Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. International journal of antimicrobial agents. 2020;56:106054.
• Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B and Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA cardiology. 2020;5:802-810
• Skulstad H, Cosyns B, Popescu BA, Galderisi M, Salvo GD, Donal E, Petersen S, Gimelli A, Haugaa KH, Muraru D, Almeida AG, Schulz-Menger J, Dweck MR, Pontone G, Sade LE, Gerber B, Maurovich-Horvat P, Bharucha T, Cameli M, Magne J, Westwood M, Maurer G and Edvardsen T. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. European heart journal Cardiovascular Imaging. 2020;21:592-598.
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H and Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395:1054-1062.